Detected ·

ImpriMed, Inc.

——

ImpriMed, Inc., a precision oncology startup analyzing patients' live cancer cells to guide chemotherapy decisions, announced NAVER D2SF has joined as a new investor, with LB Investment leading the round.

Amount
—
Stage
—
Event
Funding round
Detected
2026-09-21 00:03:32 UTC
Signal ID
529a964a-637d-40bf-a991-6ab43f7ed740

As the API returns it

{
  "id": "529a964a-637d-40bf-a991-6ab43f7ed740",
  "created_at": "2026-09-21T00:03:32.395083Z",
  "company_name": "ImpriMed, Inc.",
  "company_website_url": "www.imprimedicine.com",
  "company_linkedin_url": "https://www.linkedin.com/company/imprimed-inc",
  "event_type": "funding",
  "funding_amount": null,
  "funding_currency": null,
  "funding_stage": null,
  "message": "*ImpriMed, Inc., a precision oncology startup analyzing patients' live cancer cells to guide chemotherapy decisions, announced NAVER D2SF has joined as a new investor, with LB Investment leading the round.*"
}

Latest rounds